Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Q2 2024 vs. Q1 2024
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 5.63M | 5.59M | −34.5K (−0.6%) |
| Value | $385.1K | $281.5K | −$103.6K (−26.9%) |
New holders (2)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sea Otter Advisors LLC | – | $205 | 0.00% |
| Flow Traders U.S. LLC | 16,013 | $0 | 0.00% |
Sold out (2)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| EHP Funds Inc. | 107,964 | $5.61K |
| The PNC Financial Services Group, Inc. | 50 | $3 |